➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School
McKinsey

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ETHOSUXIMIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for ethosuximide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00088452 Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study Unknown status National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 2004-07-01 The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00088452 Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study Unknown status Children's Hospital Medical Center, Cincinnati Phase 3 2004-07-01 The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00689585 Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated McGill University Phase 2 2008-09-01 Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated McGill University Health Center Phase 2 2008-09-01 Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ethosuximide

Condition Name

Condition Name for ethosuximide
Intervention Trials
Epilepsy 2
Epilepsy, Absence 1
Pain NRS ≥ 4 1
Absence Epilepsy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ethosuximide
Intervention Trials
Epilepsy 4
Syndrome 3
Irritable Bowel Syndrome 2
Neuralgia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ethosuximide

Trials by Country

Trials by Country for ethosuximide
Location Trials
United States 24
France 3
United Kingdom 3
Egypt 2
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ethosuximide
Location Trials
Pennsylvania 2
New York 1
California 1
Colorado 1
Connecticut 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ethosuximide

Clinical Trial Phase

Clinical Trial Phase for ethosuximide
Clinical Trial Phase Trials
Phase 4 2
Phase 3 3
Phase 2 5
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ethosuximide
Clinical Trial Phase Trials
Not yet recruiting 4
Recruiting 4
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ethosuximide

Sponsor Name

Sponsor Name for ethosuximide
Sponsor Trials
University Hospital, Clermont-Ferrand 3
Bristol Royal Hospital for Children 1
National Institute of Neurological Disorders and Stroke (NINDS) 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ethosuximide
Sponsor Trials
Other 27
NIH 1
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Merck
Colorcon
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.